These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 18382208)

  • 21. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
    Shirakawa Y; Sawa Y; Takewa Y; Tatsumi E; Kaneda Y; Taenaka Y; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):624-32. PubMed ID: 16153905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy.
    Terracciano CM; Hardy J; Birks EJ; Khaghani A; Banner NR; Yacoub MH
    Circulation; 2004 May; 109(19):2263-5. PubMed ID: 15136495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing the remodeling process in heart failure: basic mechanisms and laboratory results.
    Francis GS
    Curr Opin Cardiol; 1998 May; 13(3):156-61. PubMed ID: 9649937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
    Klotz S; Burkhoff D; Garrelds IM; Boomsma F; Danser AH
    Eur Heart J; 2009 Apr; 30(7):805-12. PubMed ID: 19223317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myocardial alterations with mechanical left ventricular assist devices].
    Grabellus F; Schmid C; Levkau B; Stypmann J; Scheld HH; Baba HA
    Pathologe; 2003 Mar; 24(2):83-90. PubMed ID: 12673495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic partial unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts.
    Wang J; Tsukashita M; Nishina T; Marui A; Yoshikawa E; Muranaka H; Matsuoka S; Ikeda T
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):465-70. PubMed ID: 19185171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
    Birks EJ; Hall JL; Barton PJ; Grindle S; Latif N; Hardy JP; Rider JE; Banner NR; Khaghani A; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I57-64. PubMed ID: 16159866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanical unloading and cell therapy have a synergistic role in the recovery and regeneration of the failing heart.
    Ibrahim M; Rao C; Athanasiou T; Yacoub MH; Terracciano CM
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):312-8. PubMed ID: 22378852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure.
    Jahanyar J; Youker KA; Torre-Amione G; Koerner MM; Bruckner B; Noon GP; Loebe M
    J Heart Lung Transplant; 2008 Jul; 27(7):701-9. PubMed ID: 18582797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of native left ventricular function during mechanical circulatory support: theoretical basis and clinical limitations.
    Sakamoto T
    Ann Thorac Cardiovasc Surg; 2002 Feb; 8(1):1-6. PubMed ID: 11916435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular assist device support induces acute changes in myocardial electrolytes in heart failure.
    Monreal G; Gerhardt MA
    ASAIO J; 2007; 53(2):152-8. PubMed ID: 17413553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac recovery during mechanical assist device support.
    Maybaum S; Kamalakannan G; Murthy S
    Semin Thorac Cardiovasc Surg; 2008; 20(3):234-46. PubMed ID: 19038734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular unloading with an assist device results in receptor relocalization as well as increased beta-adrenergic receptor numbers: are these changes indications for outcome?
    Bick RJ; Grigore AM; Poindexter BJ; Schnee PM; Nussmeier NA; Gregoric ID; Shah NA; Myers TJ; Buja LM; Frazier OH
    J Card Surg; 2005; 20(4):332-6. PubMed ID: 15985133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances).
    Kirklin JK; Holman WL
    Curr Opin Cardiol; 2006 Mar; 21(2):120-6. PubMed ID: 16470148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathologic correlates of myocardial improvement in patients supported by a left ventricular assist device.
    Segura AM; Frazier OH; Demirozu Z; Buja LM
    Cardiovasc Pathol; 2011; 20(3):139-45. PubMed ID: 20185339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in sarcomeric and non-sarcomeric cytoskeletal proteins and focal adhesion molecules during clinical myocardial recovery after left ventricular assist device support.
    Latif N; Yacoub MH; George R; Barton PJ; Birks EJ
    J Heart Lung Transplant; 2007 Mar; 26(3):230-5. PubMed ID: 17346624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in alpha adrenoreceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device.
    Grigore A; Poindexter B; Vaughn WK; Nussmeier N; Frazier OH; Cooper JR; Gregoric ID; Buja LM; Bick RJ
    J Heart Lung Transplant; 2005 May; 24(5):609-13. PubMed ID: 15896760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular-assist devices for the treatment of chronic heart failure.
    Drakos SG; Charitos EI; Nanas SN; Nanas JN
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):571-84. PubMed ID: 17489679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased myocardial chromogranin a expression and colocalization with brain natriuretic peptide during reverse cardiac remodeling after ventricular unloading.
    Wohlschlaeger J; von Winterfeld M; Milting H; El Banayosy A; Schmitz KJ; Takeda A; Takeda N; Azhari P; Schmid C; August C; Schmid KW; Baba HA
    J Heart Lung Transplant; 2008 Apr; 27(4):442-9. PubMed ID: 18374882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.